Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Astellas Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for ALPMY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

01 May 2016 ValuEngine, Inc. 11 $25.00

Thomson Reuters Stock Report - Astellas Pharma Inc (4503-TO)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Apr 2016 Thomson Reuters Stock Report 11 $25.00

ASTELLAS PHARMA INC (ALPMY=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 Apr 2016 Pechala's Reports 2 $25.00

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review Summary Astellas Pharma Inc. (Astellas) is one of ...

14 Apr 2016 GlobalData 335 $300.00

Wright Investors Service Comprehensive Report for Astellas Pharma Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

08 Apr 2016 Wright Reports 56 $75.00

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review Summary Astellas Pharma Inc. (Astellas) is one of ...

09 Mar 2016 GlobalData 298 $300.00

Will Astellas Pharma Inc Deliver Long-Term Returns?

03 Feb 2016 Sadif Analytics Prime 11 $25.00

4503.T - Event Transcript of Astellas Pharma Inc conference call, Jan. 29, 2016 / 12:00AM ET

Edited Event Transcript of 4503.T conference call, Jan. 29, 2016 / 12:00AM ET Boston, Jan 29, 2016 (Thomson StreetEvent...

29 Jan 2016 Thomson Reuters StreetEvents 14 $75.00

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review Summary Astellas Pharma Inc. (Astellas) is one of ...

08 Dec 2015 GlobalData 330 $300.00